| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.63B | 1.58B | 1.49B | 1.40B | 1.23B | 928.70M |
| Gross Profit | 1.12B | 1.27B | 1.22B | 486.20M | 428.40M | 297.90M |
| EBITDA | 263.90M | 262.10M | 241.90M | 230.90M | 214.60M | 137.70M |
| Net Income | 89.60M | 96.20M | 105.50M | 112.50M | 78.50M | 33.60M |
Balance Sheet | ||||||
| Total Assets | 2.35B | 2.11B | 1.87B | 1.79B | 1.67B | 1.62B |
| Cash, Cash Equivalents and Short-Term Investments | 20.80M | 28.90M | 126.90M | 101.70M | 83.90M | 31.70M |
| Total Debt | 668.90M | 434.20M | 296.80M | 299.40M | 296.40M | 350.00M |
| Total Liabilities | 1.21B | 943.40M | 762.10M | 742.00M | 719.70M | 730.90M |
| Stockholders Equity | 1.15B | 1.17B | 1.11B | 1.04B | 949.60M | 888.30M |
Cash Flow | ||||||
| Free Cash Flow | 58.30M | 70.40M | 86.90M | 61.20M | 117.20M | 130.30M |
| Operating Cash Flow | 193.20M | 201.70M | 193.70M | 168.00M | 194.10M | 168.40M |
| Investing Cash Flow | -300.90M | -296.20M | -120.40M | -112.90M | -75.50M | -177.80M |
| Financing Cash Flow | 98.10M | -3.00M | -46.60M | -38.00M | -65.90M | 16.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £1.16B | 12.86 | 7.90% | 4.43% | 7.83% | -7.40% | |
69 Neutral | £1.25B | 28.03 | 6.07% | ― | 32.27% | ― | |
65 Neutral | £426.34M | 18.00 | 3.57% | 4.40% | 1.31% | 10.19% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | £79.26M | 15.26 | 5.71% | 4.92% | -0.29% | -33.41% | |
60 Neutral | £383.32M | 24.43 | 7.03% | 2.11% | 15.99% | 96.05% | |
57 Neutral | £535.97M | 44.09 | 3.10% | 2.48% | 5.58% | 66.49% |
Breedon Group PLC has announced its total voting rights in accordance with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. The company has an issued share capital consisting of 346,545,248 ordinary shares, all of which have voting rights, providing shareholders with the denominator needed to assess their interests in the company.
The most recent analyst rating on (GB:BREE) stock is a Buy with a £393.00 price target. To see the full list of analyst forecasts on Breedon stock, see the GB:BREE Stock Forecast page.
Breedon Group PLC announced that its issued share capital comprises 346,538,326 ordinary shares, with none held in treasury, which defines the total number of shares with voting rights. This announcement is in line with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, providing shareholders with the necessary information to assess their interests in the company.
The most recent analyst rating on (GB:BREE) stock is a Buy with a £397.00 price target. To see the full list of analyst forecasts on Breedon stock, see the GB:BREE Stock Forecast page.
Breedon Group PLC has announced its total voting rights in accordance with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. The company’s issued share capital consists of 346,531,291 ordinary shares, all of which have voting rights. This information is crucial for shareholders as it determines their obligation to notify any changes in their interest in the company.
The most recent analyst rating on (GB:BREE) stock is a Buy with a £5.17 price target. To see the full list of analyst forecasts on Breedon stock, see the GB:BREE Stock Forecast page.
Breedon Group PLC announced that Abicad Holding Limited, closely associated with Non-executive Chair Amit Bhatia, acquired 300,000 ordinary shares through option agreements at a price of 392.745 pence per share. This acquisition increases Abicad’s holdings to approximately 19.00% of Breedon’s total issued share capital, with potential to rise to 19.35% if further options are exercised. This move aligns with Abicad’s ongoing strategy to increase its market share in Breedon, potentially impacting the company’s shareholder dynamics and market positioning.
The most recent analyst rating on (GB:BREE) stock is a Buy with a £5.17 price target. To see the full list of analyst forecasts on Breedon stock, see the GB:BREE Stock Forecast page.
Breedon Group PLC announced that Clive Watson, a Non-executive Director and Person Discharging Managerial Responsibilities (PDMR), purchased 1,223 ordinary shares at a price of £3.712 each. This transaction, conducted on the London Stock Exchange, is reported in compliance with the UK Market Abuse Regulation, reflecting the company’s commitment to transparency in managerial dealings.
The most recent analyst rating on (GB:BREE) stock is a Buy with a £5.90 price target. To see the full list of analyst forecasts on Breedon stock, see the GB:BREE Stock Forecast page.